| GCPNX | JHQAX | GCPNX / JHQAX | |
| Total Expense Ratio | 0.63 | 0.82 | 77% |
| Annual Report Gross Expense Ratio | 1.07 | 0.82 | 130% |
| Fund Existence | 9 years | 13 years | - |
| Gain YTD | 4.542 | -2.120 | -214% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 330M | 18.7B | 2% |
| Annual Yield % from dividends | 0.59 | 0.37 | 158% |
| Returns for 1 year | 18.04 | 5.43 | 333% |
| Returns for 3 years | 47.35 | 27.80 | 170% |
| Returns for 5 years | 55.33 | 36.57 | 151% |
| Returns for 10 years | N/A | 126.63 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DGEYX | 30.38 | 0.44 | +1.47% |
| BNY Mellon Global Emerging Mkts - Y | |||
| FTZCX | 73.53 | 0.64 | +0.88% |
| FullerThaler Behvrll Uncnstd Eq C | |||
| JDEAX | 50.40 | 0.22 | +0.44% |
| JPMorgan US Research Enhanced Equity A | |||
| MEFAX | 10.44 | 0.04 | +0.38% |
| MassMutual Mid Cap Growth A | |||
| MIGPX | 17.67 | 0.05 | +0.28% |
| Morgan Stanley Inst Global Insgt A | |||